# US 2022/0033790 A1 · Microorganism for producing dicarboxylic acid, and method for producing dicarboxylic acid using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033790 A1
- Document ID: US20220033790A1
- Status: Published application
- Kind: A1
- Application number: 17/299,194
- Filed: 2019-12-04
- Published: 2022-02-03
- Earliest claimed: 2018-12-04
- Assignees: Korea University Research and Business Foundation
- Applicants: Korea University Research and Business Foundation
- Inventors: Kyoung Heon KIM; Thirumalaisamy BABU; Do Hyoung KIM; Jong Hwa LEE; Jung Moo LEE; Ho Chang LEE; Sung Ho OH; Su Han KIM; Chang Seok HYUN
- Web page: https://patentgrep.com/patent/US20220033790A1

## CPC

- C12N 9/20: Triglyceride splitting, e.g. by means of lipase
- C07K 14/40: from Candida
- C12N 15/81: for yeasts
- C12P 7/44: Polycarboxylic acids
- C12Y 301/01003: Triacylglycerol lipase (3.1.1.3)
- C12R 2001/74: Candida tropicalis
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to a Candida tropicalis cell line, which comprises a mutant gene, having improved tolerance for cytotoxicity of stromal cells, and a method for producing dicarboxylic acid using the Candida tropicalis cell line. The Candida tropicalis cell line for producing dicarboxylic acid developed according to the present invention has improved tolerance for existing stromal toxicity as well as significantly improved efficiency for producing dicarboxylic acid compared to existing cell lines, thus can be used in biological production of dicarboxylic acid and is expected to have high industrial utility.

## Claims

### Claim 1

A Candida tropicalis strain having improved tolerance to the cytotoxicity of substrates,
wherein the strain comprise a mutation in one or more genes selected from a LIP1 (lipase) gene represented by a base sequence set forth in SEQ ID NO: 1, a FAT1 (fatty acid transport) gene represented by a base sequence set forth in SEQ ID NO: 2, and an MRP1 (multidrug resistance protein) gene represented by a base sequence set forth in SEQ ID NO: 3, or
wherein the strain is transformed with one or more mutated genes selected from the mutated LIP1 gene, the mutated FAT1 gene and the mutated MRP1 gene.

### Claim 2 (depends on 1)

The Candida tropicalis strain of claim 1, wherein the mutated LIP1 (lipase) gene is set forth in SEQ ID NO: 4.

### Claim 3 (depends on 1)

The Candida tropicalis strain of claim 1, wherein the mutated FAT1 (fatty acid transport) gene is set forth in SEQ ID NO: 5.

### Claim 4 (depends on 1)

The Candida tropicalis strain of claim 1, wherein the mutated MRP1 (multidrug resistance protein) gene is set forth in SEQ ID NO: 6.

### Claim 5 (depends on 1)

The Candida tropicalis strain of claim 1, wherein the Candida tropicalis strain has a blocked β-oxidation pathway.

### Claim 6 (depends on 1)

The Candida tropicalis strain of claim 1, wherein the substrate is a fatty acid methyl ester (FAME).

### Claim 7 (depends on 6)

The Candida tropicalis strain of claim 6, wherein the fatty acid methyl ester substrate comprises one or more selected from C6-C20 fatty acid methyl esters.

### Claim 8 (depends on 1)

A method for producing a dicarboxylic acid (DCA), the method comprising:
incubating the Candida tropicalis strain defined in claim 1 in a medium with a substrate.

### Claim 9 (depends on 8)

The method of claim 8, wherein the substrate is a fatty acid methyl ester (FAME).

### Claim 10 (depends on 9)

The method of claim 9, wherein the fatty acid methyl ester comprises one or more selected from C6-C20 fatty acid methyl esters.
